PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
about
Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India.PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisininGenetic variation: effect on prostate cancer.Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose.Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy.Supporting Asian patients with metastatic breast cancer during ixabepilone therapy.Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.Level of evidence for therapeutic drug monitoring of taxanes.Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses.Nuclear receptors and drug metabolism for the personalization of cancer therapy.Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine.Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.Clinical efficacy of adjunctive G-CSF on solid tumor and lymphoma patients with established febrile neutropenia.Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy.Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer.High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.Genetic variability of PXR in Saudi Arabians.Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.Pharmacogenomic diversity in Singaporean populations and Europeans.
P2860
Q33441582-720754C8-4CD6-4FA4-A6FA-5A4B4E04AAC4Q34129977-01CA1F9D-4CA6-4653-B19D-6F2C25986569Q34663656-C11F0A01-DB05-410D-8B02-9EF425C4347DQ35674153-25E58B47-5842-4EC3-BA05-AB67DAD67940Q36769011-2CD33ECB-B1B8-4E1B-8912-8A1D8E84D387Q37513374-8F80E63B-E050-44A9-8DC9-BE25687E5479Q37682258-739FC72B-80E8-42FB-B059-F6E34DC7336FQ37725978-D8421076-9403-4FB3-9689-0A2B7BFB863DQ37788732-5CE608F2-B835-4B11-9BC1-ACA00BDD8F80Q38166454-3352507D-E8DA-4460-9C2C-5A00DF6DA559Q38427249-E89C8599-26DE-4CA3-A716-31D38640CCB2Q38704025-B4A1108B-E175-41CE-B51D-F49C69227CCFQ38937177-E1F2193E-2B60-4D85-AD23-D1E54D7EFEB2Q39359391-4BF86DE3-1274-4A53-8229-434B4E308B3CQ40225665-B40352ED-02B9-45A3-916A-1E33E68283ADQ40363722-41866ADB-6EE7-4913-97A0-92E0F3479BDFQ40755361-EEBF63A4-31C5-462E-823B-88917AF71206Q41441391-FE5CEBBB-53F2-4B7C-8EA9-65A0110E3252Q43906898-84552933-3C13-4C31-A38E-45DBC94EDD50Q49332317-7F91FEBD-3B46-4106-9E9F-44936404729BQ50053868-C93B801B-66CB-46BD-AFE0-F178073E67CFQ51075367-92CAF681-A008-408E-9429-0B92C7B8E67DQ51297212-C111DBE2-BAA8-420A-AD6A-1302FF7AE31AQ53541756-69628E9E-206E-4565-83DC-80DC6B0216B6
P2860
PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@en
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@nl
type
label
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@en
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@nl
prefLabel
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@en
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@nl
P2093
P2860
P356
P1476
PXR, CAR and HNF4alpha genotyp ...... doxorubicin in Asian patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500478
P577
2007-09-18T00:00:00Z